These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1527728)

  • 1. Shifts in the dose-effect relationship for the nephropathy induced by cadmium-metallothionein in rats after a reduction in renal mass.
    Zalups RK; Gelein RM; Cherian MG
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1256-66. PubMed ID: 1527728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reductions in renal mass and the nephropathy induced by mercury.
    Zalups RK
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):366-79. PubMed ID: 9144453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DMPS as a rescue agent for the nephropathy induced by mercuric chloride.
    Zalups RK; Gelein RM; Cernichiari E
    J Pharmacol Exp Ther; 1991 Jan; 256(1):1-10. PubMed ID: 1671092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of different degrees of reduced renal mass on the renal and hepatic disposition of administered cadmium.
    Zalups RK
    J Toxicol Environ Health; 1997 Jun; 51(3):245-64. PubMed ID: 9183381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive losses of renal mass and the renal and hepatic disposition of administered inorganic mercury.
    Zalups RK
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):121-31. PubMed ID: 7839359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal metallothionein metabolism after a reduction of renal mass. II. Effect of zinc pretreatment on the renal toxicity and intrarenal accumulation of inorganic mercury.
    Zalups RK; Cherian MG
    Toxicology; 1992; 71(1-2):103-17. PubMed ID: 1729759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrotoxicity of repeated injections of cadmium-metallothionein in rats.
    Wang XP; Chan HM; Goyer RA; Cherian MG
    Toxicol Appl Pharmacol; 1993 Mar; 119(1):11-6. PubMed ID: 8470114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
    Zalups RK
    J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cadmium-Metallothionein nephropathy: relationships between ultrastructural/biochemical alterations and intracellular cadmium binding.
    Squibb KS; Pritchard JB; Fowler BA
    J Pharmacol Exp Ther; 1984 Apr; 229(1):311-21. PubMed ID: 6707945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mercuric chloride-induced cytotoxicity and compensatory hypertrophy in rat kidney proximal tubular cells.
    Lash LH; Zalups RK
    J Pharmacol Exp Ther; 1992 May; 261(2):819-29. PubMed ID: 1578387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nephrotoxicity of intravenously administered cadmium-metallothionein: effect of dose, mode of administration, and preexisting renal cadmium burden.
    Vestergaard P; Shaikh ZA
    Toxicol Appl Pharmacol; 1994 Jun; 126(2):240-7. PubMed ID: 8209377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chlorpromazine pretreatment on cadmium toxicity in the male Wistar (WF/NCr) rat.
    Shiraishi N; Rehm S; Waalkes MP
    J Toxicol Environ Health; 1994 Jun; 42(2):193-208. PubMed ID: 8207755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal toxicity of cadmium-metallothionein and enzymuria in rats.
    Suzuki CA; Cherian MG
    J Pharmacol Exp Ther; 1987 Jan; 240(1):314-9. PubMed ID: 2879904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal accumulation of cadmium and nephropathy following long-term administration of cadmium-metallothionein.
    Min KS; Onosaka S; Tanaka K
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):102-9. PubMed ID: 8917681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancy between the nephrotoxic potencies of cadmium-metallothionein and cadmium chloride and the renal concentration of cadmium in the proximal convoluted tubules.
    Dorian C; Gattone VH; Klaassen CD
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):161-8. PubMed ID: 7839364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of parameters of cadmium exposure with onset of cadmium-induced nephropathy in rats.
    Goyer RA; Cherian MG; Delaquerriere-Richardson L
    J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):89-100. PubMed ID: 6520742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative toxicity of cadmium-metallothionein and cadmium chloride on mouse kidney.
    Nordberg GF; Goyer R; Nordberg M
    Arch Pathol; 1975 Apr; 99(4):192-7. PubMed ID: 1115684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of nephrotoxicity induced by repeated administration of cadmium chloride in rats.
    Sudo J; Hayashi T; Kimura S; Kakuno K; Terui J; Takashima K; Soyama M
    J Toxicol Environ Health; 1996 Jul; 48(4):333-48. PubMed ID: 8691505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.